|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 71.54 USD | +1.50% |
|
-8.26% | +7.79% |
| 22/07 | Dexcom Insider Sold Shares Worth $2,041,999, According to a Recent SEC Filing | MT |
| 16/07 | Truist Adjusts Price Target on DexCom to $87 From $80, Maintains Buy Rating | MT |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Neutral | Neutral | Neutral |
| Resistance | 78.19 | 78.19 | 82.26 |
| Spread/Res. | -8.50% | -8.50% | -13.03% |
| Spread/Supp. | +6.22% | +24.29% | +30.07% |
| Support | 67.35 | 57.56 | 55 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- DXCM Stock
- Charts DexCom, Inc.
Select your edition
All financial news and data tailored to specific country editions
